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Abstract 
 
Context: In most parts of the United Kingdom current cardiac services neglect assessment and 
primary prevention of cardiovascular disease in first degree relatives of patients with proven 
premature coronary heart disease.  First degree relatives are at a higher risk than the general 
population by virtue of shared lifestyle risk and genetic factors to index cases.  
Objectives: This study aimed to identify first degree relatives of patients with proven coronary heart 
disease and assess their cardiovascular risk, using various cardiovascular risk assessment tools. We 
also aimed to assess the effectiveness of cardiovascular risk reduction services on the cardiovascular 
risk of the individual. 
Design, Setting, and Participation: A qualitative study was conducted at Sandwell Hospital.  43 
participants aged 18- 74years were recruited. 
Results: The mean age of the cohort was 42(±4). 66% were under the age of 40years. At the 
baseline appointment 30% of the cohort, had a systolic blood pressure greater than 140mmHg, mean 
140(±14.8) mmHg and 28% had a diastolic blood pressure greater than 90mmHg, mean 94(±2.12) 
mmHg. 82% of south Asians had a BMI greater than 23 Kg/m2.  63% of non south Asians had a BMI 
greater than <25 Kg/m2. 37%. 61% of the cohort’s total cholesterol was greater than 5mmol/l, mean 
7.1(±1.8) mmol/l. 64% had triglycerides greater than 2.0mmol/l, mean 2.75(±0.49) mmol/l. The high 
density lipoprotein for males, 11% had a level greater than less than 1.0mmol/l, mean 1.2(±0.2) 
mmol/l, 4% of females had a level less than 1.2mmol/l, mean 1.4(±1) mmol/l.  The cardiovascular 
tools QRISK, ETHRISK CVD, Framingham CVD identified over 10% of the cohort as high risk at the 
baseline appointment, and at the review appointment there was no change using QRISK.  However, 
ETHRISK CVD and Framingham CVD demonstrated a risk reduction in the cohort. The tools varied in 
their selection of high risk, moderate risk and low risk.  ETHRISK CHD and Framingham CHD and 
BNF identified 7% as high risk. Referral to specialist services was initiated with 14% referred for 
investigations, 21% commenced on medication or was altered.  12% of smokers were referred to a 
smoking cessation services.  25% referred to weight management service.  32% were referred to 
Cardiologist or Lipidologist.  19% referred to exercise on prescription. 
Conclusions: The study identified risk factors in individuals who would not conventionally access the 
current National Health Service Health Checks programme and should therefore be seen as 
complementary to NHS Health Checks. 66% were under the age of 40years who accessed the 
service. This population would not be able to access the systematic Health Checks programme 
provided by the National Health Service.  This study therefore, illustrates the benefits of providing a 
tailored service for young individual’s potentially high risk and susceptible to premature CVD. This 
service enabled first degree relatives to choose a healthier lifestyle to reduce their risk of 
cardiovascular event in the future. 
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Chapter 1- Introduction  
 
It is known that, cardiovascular disease (CVD) is still the leading cause of premature 
morbidity and mortality in the UK (British Heart Foundation, 2007), and therefore 
prevention is now becoming of significant importance. Primary prevention is highly 
cost effective and there is now a focus on primary prevention in the current National 
Health Service, with a multitude of recent strategic initiatives.  
 
The Public Health White Paper, ‘Choosing Health’ (Department of Health, 2005), 
demonstrated a government commitment towards providing opportunity and support, 
which enabled individuals to lead healthier lives.  This has been followed by recent 
initiatives such as the NHS Next Stage Review (2008), which identifies a need to 
change the emphasis of the NHS from being an illness management service to a 
health promoting and health preservation service. Linked to this vision is the recently 
launched NHS Health Checks Programme (Department of Health, 2008), which aims 
to offer access to cardiovascular risk assessment and a range of interventions, 
targeted to reduce cardiovascular risk at an individual level. None of these recent 
initiatives is new in terms of an aspiration for cardiovascular services.  
 
Almost 10 years ago, the National Service Framework (NSF) for Coronary Heart 
Disease (Department of Health, 2000), in chapters 1 and 2, highlighted a need to 
deliver population and individual level cardiovascular prevention services. Whilst 
other chapters of the NSF have been delivered in an exemplary manner, with 
significant improvement in services across the spectrum of CVD, prevention has not 
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received the same magnitude of attention that downstream services have benefited 
from.   
 
Embedded within the NSF was the recommendation that first degree relatives 
(FDRs) of patients with premature coronary heart disease (CHD) should be offered 
access to cardiovascular prevention.  FDRs are defined as individuals such as the 
spouse, brothers, sisters and children. Studies, which will be discussed later, have 
demonstrated that this cohort of individuals is at a particularly high risk of CVD. 
Siblings have elevated risk due to the acquisition of risk factors from shared lifestyles 
and/or a genetic predisposition to premature heart disease. Offspring and partners of 
patients with premature disease also have increased risk for similar reasons (Chow, 
Pell, Walker, O'Dowd, Dominiczak & Pell, 2007). 
 
Studies such as the Heart Protection Study (Wilmshurst, 2002) and numerous other 
risk factor intervention studies, have shown how effective interventions, such as 
smoking cessation advice, dyslipidaemia therapy and physical activity, are in the 
primary prevention setting (these studies will be discussed in chapter 2). Taking into 
account that FDRs of patients with premature CHD (< 55 year old male, <65 year old 
females) which are considered a high risk population; one would predict a significant 
number of events could be avoided by targeting primary prevention at this group of 
individuals.  
 
Since many FDRs are below the age of forty years, the recently launched Health 
Checks programme would not invite many of these individuals for cardiovascular risk 
assessment and therefore deny many of these high risk individuals access to 
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lifestyle risk management services and therapeutic interventions. Thus, there is a 
need to assess FDRs regardless of age. The rationale of this study is to initially 
assess FDRs over the age of eighteen and if they are identified as “at risk”, then to 
provide intervention and support. As a result, this study would provide a primary 
prevention service for FDRs over the age of eighteen and would consequently 
complement the Health Checks programme and in addition deliver a key 
recommendation of the NSF.  
 
However, there have been few examples of how systematic services for this group 
might be developed and delivered in a structured manner. Two sources of FDR exist; 
firstly, there are a considerable number of new cases of premature CHD diagnosed 
daily in England; therefore, there is an incident population of FDRs who should be 
offered access to primary prevention services. Secondly, there exists a prevalent 
population of FDRs, by virtue of CHD patients, who have had premature CHD 
diagnosed in the past and have been discharged from acute care to their general 
practitioner.  
 
This study will report on the development and efficacy of services for the former 
group of FDRs who are identified from the acute sector. In addition, cardiovascular 
risk assessment will be quantified by the Framingham risk calculator and will be used 
to provide health promotion interventions to the FDR. It will go on to compare 
Framingham (Joint British Society 2, 2005) tools with other cardiovascular risk 
assessment tools, such as ETHRISK (Brindle, May, Gill, Cappuccio, D’Agostino, 
Fischbacher & Ebrahim; 2006) and QRISK II (Hippisley-Cox,  Coupland, 
Vinogradova, Robson, Minhas, Sheik & Brindle, 2008). 
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In light of the key works as outlined above the objectives of this study are as follows: 
1. To identify first degree relatives of patients with proven coronary heart disease 
and assess their cardiovascular risk 
2. To compare different cardiovascular risk assessment tools 
3. To assess the effectiveness of cardiovascular risk reduction services on the 
cardiovascular risk of the individual. 
 
Hypotheses 
 
H0 Cardiovascular risk tools are not capable of predicting cardiovascular disease 
in FDRs of patients with premature CHD.   
H1 FDRs can be identified by proactive case finding 
H2 Provision of lifestyle risk management services in FDR can lead to risk 
reduction and modify behaviour. 
 
This study builds upon the existing literature that all FDRs should be detected early 
for the onset of CVD and the absolute risk calculated using cardiovascular algorithm 
and the risk communicated to the FDR. For the purpose of this study it is proposed 
that FDRs of patients admitted with CHD should be offered primary prevention 
service to assess CVD risk. 
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Chapter 2 – Literature review 
 
2.1 Definition of Cardiovascular Disease (CVD)  
 
CVD is a general term used to describe disorders that can affect the heart and the 
body’s system of arteries and veins.  Atherosclerosis is defined as a gradual build of 
fatty deposits and debris in the arteries, which causes the narrowing of the arteries. 
The consequences of this may contribute to a myocardial infarction, angina or 
congestive heart failure.  Therefore, risk factors for atherosclerosis need to be 
addressed to reduce the risk CVD in the general population.                           
 
CVD is the leading cause of premature death and a major cause of disability in the 
United Kingdom.  It consumes a vast amount of resources in primary and secondary 
care, approximately £29.1 billion a year (Luengo-Fernandez, Leal, Gray, Petersen, & 
Rayner, 2006).  Comparison of mortality rates from CHD in England with those in 
countries such as Japan, France and Spain, suggest that 80% of deaths in England 
could be avoided through improved treatment and active prevention (Kearney & 
Chellaswamy, 2009., World Health Organization, 2005).  According to the British 
Heart Foundation (2007), mortality rates from CHD have continued to decline 
steadily since the late 1960s. Unal, Critchley and Capewell (2004) suggest that the 
decline in mortality could be related to the improvements in population risk factors 
and in medical treatments for patients with coronary disease. These include 
secondary prevention strategies such as improvements in diet and the introduction of 
smoking cessation services, which have contributed substantially to the declines 
seen between 1981 and 2000. Furthermore, a 40% reduction in cardiovascular 
Chapter 2: Literature Review 
Ranjit Kaur Dhillon 6
deaths in people under the age of 75 years has been observed since the 
implementation of the NSF (Cardio & Vascular Coalition 2008). Nevertheless, as 
indicated earlier, the NSF (Department of Health, 2000) has neglected to 
systematically deliver services which incorporate chapter 1 and chapter 2, which 
focus on primary prevention. 
 
2.2 National policies and recommendations 
 
Before a primary prevention service can be started, the target group for a service 
needs to be established.  National strategies have evolved to identify individuals at 
the highest risk of a cardiac event and to provide cost-effective treatments and 
lifestyle advice to the individual so as to reduce the likelihood of an event (Kennedy 
2008). In April 2008 the Department of Health announced plans to introduce a 
comprehensive vascular risk assessment and management programme, for all 
people aged forty to seventy four years old, based on recommendations by the 
National Screening Committee. It is estimated to cost around £250 million per year. 
(Department of Health, 2008).  The key aims of the programme are as follows: 
• To detect people at a high risk of CVD aged forty to seventy four years; 
• Estimate cardiovascular risk using various algorithms; 
• Enable the prevention of diabetes in many of those at increased risk of 
diabetes; 
• To reduce premature mortality and to increase life expectancy; 
• To reduce the overall population risk by reducing smoking rates, changing 
diets and increasing physical activity. In this way, identifying individuals at 
increased risk who could benefit from specific individual interventions; 
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• Reduction of inequalities arising from socio-economic, ethnic and gender 
inequalities (Khunti, Hiles and Davies 2008). 
As stated, previously, the preliminary aim of the CVD programme is to identify 
people at high risk. 
2.3 Calculating cardiovascular risk. 
 
National guidelines for the prevention of CHD recommend the use of absolute risk 
profiles to guide decisions concerning treatment. This approach allows clinicians to 
target treatment at people who face the greatest risk of CVD (Joint British Society, 
2005).  Calculating cardiovascular risk enables clinicians to combine risk factor 
information and calculate the risk of a cardiovascular event within a specified time 
period. The National Institute of Clinical Excellence (NICE)(2008), advocates that 
high risk people should have their CHD/CVD risk estimated using a risk assessment 
tool.  It has been suggested by Moon, Royston, Verguwe, Grobbee and Altmon 
(2009) that cardiovascular algorithms have a role in decision making and the future 
management of individuals. 
 
 There are numerous risk assessment algorithms available, which have been 
recommended to guide primary prevention strategies (Chauhan, 2007). The majority 
of cardiovascular algorithms use the Framingham equation. This equation was 
created using data from 5573 individuals who were followed up for 12 years.  The 
traditional risk factors which are included in all of the algorithms include age, gender, 
blood pressure, cholesterol and smoking (Coleman, Stevens & Holman 2007). The 
Framingham Heart Study was a public health study based in America.  It began in 
1948 and over 10,000 residents enrolled.  The study's objective was to learn why 
people get CVD, how it evolves and results in death in the general population. The 
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study documented population characteristics such as blood pressure, diabetic status 
and smoking, together with the causes of death, over a period of 50 years.  From 
these data, various risk factors for CHD, Stroke and total CVD have been defined 
and quantified (Dawber, Mealows & Moore, 1951).   
 
According to National Institute Clinical Excellence (2008), the current risk estimation 
is based upon the modified American Framingham equation which has limitations 
regarding the UK population. The Framingham equations can over / under estimate 
risk depending on the population being assessed. For example, the Framingham 
model does not take into account ethnicity and no allowances are made for family 
history of premature CHD. The CVD risk in south Asians is 40% higher than the 
general population (British Heart Foundation, 2007). NICE lipid modification (2008) 
recommended that the estimated CVD risk for men with south Asian background 
should be increased by 1.4.  However, recently cardiovascular tools have been 
developed which take into consideration ethnicity.   A recent report supports that the 
Framingham risk score may underestimates risk in women by 12% and 
overestimates that in men by 23%, when compared to the QRISK score (Hippisley-
Cox, Vinogradova, Robson, May & Brindle, 2007).  
 
2.4 Cardiovascular tools 
 
QRISK: is a new cardiovascular disease risk calculator. It includes all the traditional 
risk factors, but also includes body mass index, family history of CVD, social 
deprivation and use of antihypertensive treatment ( Hippisley-Cox, Coupland, 
Vinogradora, Robson, Minhas, Sheik & Brindle, 2008) 
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ETHRISK: A study that was conducted to recalibrate on the existing Framingham 
risk score to produce a web based tool for estimating ten year risk of CHD and CVD 
in black and ethnic minority groups.  It consisted of 8,000 males and females, aged 
35-54.  The study concluded that in the absence of current cohort studies in the UK 
that includes significant numbers of black & ethnic minority groups; this algorithm 
provides a pragmatic solution to include people from ethnic backgrounds (Brindle et 
al. 2006).  Although this tool is not ideal it would have partially prevented inequalities 
in CVD prevention that are not easily overcome by subjective judgement (Cappuccio, 
2008). 
 
The Joint British Societies guidelines (2005) recommend risk stratification based on 
the probability of CVD, as opposed to coronary heart disease or other outcomes. 
The charts published in the British National Formulary are based on those given in 
the Joint British Society guidelines (2005) 
 
2.5 Communicating cardiovascular risk. 
 
This study looks at FDRs who are at risk, where the term ‘risk’ is defined as a 
situation or an event where something of human value is at stake and where the out 
come is uncertain (Rosa, 2003). Absolute risk refers to the risk of developing the 
disease over a period of time.  CVD risk can be estimated for over a ten year period. 
Risk can be expressed in either percentage or pictorial format (Goodyear-Smith, 
Arroll, Chan, Jackson, Wells, & Kenealy, 2008; Lindsay & Gaw, 1997).  The rationale 
for estimating CVD risk is based on the major risk factors because:   
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i) CVD is multi-factorial in origin; 
ii) Risk factors tend to cluster; 
iii) Co-existent risk factors tend to have multiplicative effect on CVD risk (JBS2); 
 
According to O'Conner, Fiest, Rosta, Tetroe, Enwhistle, Llewellyn-Thomas Entwistle, 
Rostom, Fiset, Barry and Jones (2002) an ‘open two-way’ exchange of information 
and opinion about risk, leads to a better understanding about clinical decisions.  This 
is supported by Edwards, Elwyn and Mulley (2002) who advocate that this definition 
moves away from the philosophy that information is communicated only from 
clinician to the individual and that the individual accepts the information without 
questioning the clinician further. The two-way exchange of information and opinion is 
important if decisions about treatment are to reflect the attitudes to risk of the people 
who will live with outcomes.  Therefore, this is not a unilateral decision but a shared 
decision between patient and clinician (Goodyear-Smith et al. 2008; NICE lipid 
modification, 2008).   
 
The NICE lipid modification (2008) guidelines support good communication skills 
between the clinician and individual. Recommendations of treatment / intervention 
should take into account the patient’s needs and preferences. People at high risk of 
CVD or with established CVD should have the opportunity to make informed 
decisions about their care and treatment, in partnership with their healthcare 
professionals. Clinicians should always be aware that all CVD risk estimation tools 
can provide only an approximation of CVD risk. Interpretation of CVD risk scores 
should always reflect informed clinical judgement (Willots, 2009).    
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2.6 Risk Factors 
 
The treatment and prevention of CVD focuses on reducing the development and 
destabilisation of coronary plaques. Modifiable risks such as smoking, physical 
inactivity, hypertension, diet, high plasma glucose level and the non-modifiable risk 
factors of age, gender and family history of premature CHD are epidemiologically 
strongly associated with CHD (Glick, 2002).  Recent epidemiological studies such as 
EUROSPIRE II (2001), the Heart Protection Study (Wilmshurst, 2002) and 
EUROACTION (Wood, Kotseva, Connolly, Jennings, Mead, Holden, De Bacquer & 
De Backer,2004) constantly report under utilization of evidence-based preventive 
treatment and inadequate management of risk factors in the overall population at risk 
of CVD. There is substantial evidence that indicates risk factor modification may 
reduce the possibility of developing CVD in the first place and improves outcomes in 
those who already had CVD (Joint British Society 2, 2005, Wang & Widlansky, 
2009).  
 
In recent years, the development of CVD guidelines has acknowledged the 
multifactorial nature of CVD. Often, a treatment focuses on a single risk factor that 
might lower risk by up to 20%–30%, but such a strategy leads to the “missing” of 
those patients who are at long-term risk of disease and consequently to chronic sub-
optimal management of the disease (Emberson, Whincup, Morris, Walker & Ebrahim 
2004).  Multifactorial risk reduction has resulted in a positive shift towards managing 
a patients total cardiovascular  risk, as demonstrated by the incorporation of tools for 
calculating cardiovascular risk into recent treatment guidelines (National Cholesterol 
Education Programme, 2001., De Backer, Ambrosioni, Borch-Johnsen, Brotons, 
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Cifkova, Dallongeville, Ebrahim, Faergeman, Graham, Mancia, Cats, Orth, Perk, 
Pyorala, Rodicio, Sans, Sansoy, Sechtem, Silber, Thomsen & Wood, 2003,. Joint 
British Society 2, 2005) 
 
2.7 Non-modifiable risk factors 
 
2.7.1 Age and Gender 
Although the majority of the emphasis is placed on modifiable risk factors, it is 
imperative that non-modifiable risk factors are not neglected.  Age plays an important 
role in the risk equation. An increased risk of CVD complications and the prevalence 
of other risk factors regardless of gender are associated with increasing age. Glick 
(2002) suggested that the majority of new CHD events occur in both men and 
women after the age of 65 years.  Therefore, the majority of all deaths which are due 
to CHD are recorded among people 65 years of age and over.  However, the 
Framingham Heart Study calculates a lifetime risk of developing CHD.  In a cohort of 
7,733 study participants, the lifetime risk was estimated to be greater in men aged 40 
years compared to women of the same age.  
NICE (2008) the lipid modification report recommends that all individuals aged 75 or 
older should be considered at increased risk of CVD, particularly those who have 
other risk factors, such as hypertension. Assessment and treatment of these patients 
should be guided by the benefits and risks of treatment, informed preference and co-
morbidities.  
 
A CHD event in the first two decades of life is rare, becoming more prevalent after 
the age of 30 and more evident in males than females below the age of 60 years.  
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Beyond the age of 60 years, CHD rates in females increase and the rate approaches 
that of males.  The population data on CHD mortality indicates that CHD risk in 
females’ increases with age.  It has been argued that this is due to the natural 
menopause occurring at different ages in individuals. Studies have demonstrated 
that women are relatively protected against CHD whilst in premenopausal years 
(Colditz, Willett, Stampher, Rosner, Speizer & Hennekens, 1987). The majority of 
observational epidemiological studies that examined the role of hormone 
replacement therapy in women without established heart disease have consistently 
demonstrated a lower incidence of cardiac events among users versus non-users.  A 
recent meta-analysis showed an approximate 35% reduction in CHD events among 
users of hormone replacement therapy (Mosca, Collins, Herrington, Mendelsohn, 
Pasternak, Robertson, Smith & Wenger, 2001) (Grodstein, Stampfer, Colditz,,Willett, 
Manson, Joffe, Rosner, Fuchs, Hankinson, Hunter, Hennekens & Speizer 1997)    
 
2.7.2 Family History 
Family history of premature disease contributes to an increased risk of CVD and risk 
factors in FDRs (Murabito, Pencina, Nam, D'Agostino, Wang, Lloyd-Jones & 
O'Donnell 2005). Clinicians use self-reported information about family history to 
calculate the risk of CVD in their patients.  The information available to the clinician, 
concerning family history is limited, due to the fact that patients themselves have 
inadequate information about their relative’s medical history. Identifying a person 
with a positive family history is essential to reduce incidence of CVD.  
Reporting of family history of premature CVD has been included in the National 
Screening guidelines (Department of Health, 2008). Consequently this highlights an 
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area where health professionals need to educate their patients on the presence 
and/or relevance of family history to a disease.  There is a need to clarify within 
families the associated risk to an individual and in turn enhance primary prevention 
services (Murabito, Nam, D'Agostinao, Lloyd, O'Donnell, & Wilson, 2004).  
Premature death from CAD clusters in families, Eaton Bostom, Yanek, Laurino, 
McQuade, Hume and Selhub (1996) suggested that the risk of developing premature 
CHD was increased more than threefold when any FDR was affected, and almost by 
six fold when the FDR developed CHD before the age of 45 years or when at least 
two first degree relative had history of CHD.  Therefore, primary prevention 
guidelines urge screening of FDR for the presence of cardiovascular risk factors.  A 
study conducted by Becker, Yook, Moy, Blumenthal and Becker (1998) identified that 
among siblings of patients with premature CHD, 80% of black men and women and 
70% of white men and women had treatable risk factors.   
A recent study by Murabito et al. (2005) suggested that it still remains debateable 
whether family history alone is an independent risk factor and for whether the issue 
is a genetic rather than family behaviour.  A positive family history seems attributable 
to the familial aggregation of genes or to shared environment; diet, living conditions, 
lifestyle habits, and occupation (Mortia & Nagai, 2005).   
Nevertheless, a case-control study conducted in Italy over a period of four years 
examined those people with premature CHD which was defined as documented 
myocardial infarction with a significant occlusion greater than 50% in a major 
coronary artery in people younger than 60 years of age. The number of acute 
myocardial infarctions according to family history was estimated using unconditional 
logistic regression, adjusting for other acute myocardial infarction risk factors and 
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family size. The results of the study indicated that by having one or more FDRs the 
odds ratio was doubled and for those with two or more FDRs the odds ratio was 
tripled. This was also similar to those with an affected parent or sibling, sex, age at 
diagnosis of the person or the relative. The study concluded that family history of 
ischemic heart disease is an independent risk factor for CHD in people younger than 
60 years of age and indicated significant correlation between early onset of CHD and 
family history.   As a result, it could be suggested that management and intervention 
of modifiable risk factors may be beneficial for those with family history at a younger 
age (Bertuzzi, Negri, Alessandra Tavani & La Vecchia, 2003).  
 
2.7.3 Ethnicity 
South Asians (SA) originate from the Indian sub continent and represent one fifth of 
the world’s population.  It is widely accepted that SA have a 40 - 60% increased risk 
of developing CHD when compared with other populations (Bhopal, Fischbacher, 
Vartianinen, Unwin, White, & Alberti 2005).  Epidemiological studies showed that the 
migrant population of SA descent have a higher risk of ischaemic heart disease than 
the general population.  They have the highest risk of developing CVD at a younger 
age in comparison to other ethnic groups (Ramaraj & Chellappa 2008).  The World 
Health Organisation, warned countries about the rising burden of heart disease 
among SA. The greatest global increase in diabetes is projected in India by 2025. In 
rural settings, the prevalence of diabetes is higher in the urban communities.  In the 
UK, the prevalence of diabetes in SA is around 20%, studies by Mather, Chaturvedi 
and Fuller (1998), Chaturvedi and Fuller (1996) showed that South Asian immigrants 
with diabetes have a three to four fold higher mortality rate due to CVD than people 
from other ethnic groups. 
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A systematic review (Kurian & Cardarelli 2007) suggested that CVD is the leading 
cause of death in United States. To expand current understanding of the factors 
associated with ethnic disparities in CVD risk factors, sixteen studies carried out in 
America were reviewed, with the majority finding that diabetes was significantly 
higher within the minority groups. Also, hypertension was significantly higher in 
blacks than whites.  No population group was found to be consistently of a higher or 
lower prevalence of obesity or hypercholesterolemia.  Mexican Americans had a 
lower prevalence of smoking than whites and blacks.  The American Indians had a 
significantly higher prevalence of smoking compared to whites.  Regarding physical 
activity Mexican Americans had the highest prevalence of no leisure time. This 
review demonstrates that better understanding and awareness of the disparities of 
CVD risk factors by ethnicity may aid public health professionals and clinicians to 
develop culturally sensitive interventions, prevention programmes and services 
specifically targeted to address risk.  The Euroaction (2008) study has demonstrated 
that standards of preventive cardiology can be improved.  To achieve the results 
demonstrated in the Euroaction study a similar model needs to be appropriately 
adapted taking into consideration the medical, cultural and economic settings of the 
country. 
Joint British Society guidelines (2005) have cautioned against the generalisation of 
risk predication methods as they may not be valid for SA.  Ramaraj et al. (2008) 
conducted a review to discuss the existing data on the prevalence of CVD and its 
risk factors in South Asians and found that there are no published randomised 
controlled studies supplying robust information on risk factors outcomes in South 
Asians or to test the validity of cardiovascular risk predication 
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2.8  Modifiable Risk Factors 
 
2.8.1  Smoking 
 
Cigarette smoking has been established as a risk factor for CHD independent of any 
other risk factors. The prevalence of smoking has declined since the 1960s, but it still 
remains high in some groups.  These groups include the under thirties, some ethnic 
minority groups and lower socioeconomic groups. Dawber (1980) suggested that 
there is a two to three fold increase of CHD risk in the whole population which is 
associated with cigarette smoking.  The risk rises with number of cigarettes smoked 
per day. In the 1990s, smoking accounted for 28% of male and 26% of female all 
cause vascular death aged 35 to 69 (Peto , Lopez, Boreham, Thun & Heath 1994).   
 
To achieve the greatest population health benefit, in the United Kingdom the 
guidance has emphasised two forms of smoking cessation: 
• Opportunistic, brief advice to encourage all smokers to quit and to direct them 
to effective treatment that can help.  
• Treatment services for those who would like or need help to stop (West, 
2005). 
The Department of Health (2005), has implemented a comprehensive strategy to 
reduce tobacco use in the UK, leading to the development of NHS Stop Smoking 
Services which provided psychological support and medication for the individual. 
Cigarette smoking has been established as a risk factor for CHD independent of any 
other risk factor. Smoking cessation has shown to reduce CVD mortality in 
individuals with established CVD and those without.  
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A prospective study conducted for 40 years (Clarke, Emberson, Fletcher, Breeze, 
Marmot & Shipley, 2009) assessed the life expectancy in relation to cardiovascular 
risk factors.  The study recruited 18,000 men from the civil service aged 40 to 49 
years.  The initial assessment included a medical examination and a questionnaire.  
The participant completed a questionnaire regarding medical history demographical 
information, social situation, smoking habits, body mass index and cholesterol. All 
surviving participants were contacted.  A questionnaire was sent regarding medical 
history and they were asked to visit their local surgery to ascertain information on 
blood pressure, cholesterol and smoking habits.  The findings suggest that the 
presence of smoking, cholesterol and high blood pressure predicated a three fold 
higher rate of non-vascular mortality and a ten year shorter life expectancy 
compared to those with none of the risk factors.   
 
This is supported by a further study, which compared the risk of smoking in men who 
formed their habits at different periods and the reduction in risk when smoking is 
stopped at different ages. British doctors participated in the study in 1951 and 
information concerning smoking status ascertained for 50 years.  The findings 
demonstrated men born around 1920, who continued to smoking from early 
adulthood tripled their age-specific mortality rates but, cessation at the age of 50 
halved the risk, and cessation at the age of 30 avoided almost all of it (Doll, Reto, 
Boreham & Sutherland, 2004). 
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2.8.2  Physical Activity 
Physical inactivity predisposes an individual to numerous health problems including: 
obesity, increased insulin resistance and metabolic risk factors (Fletcher, Balady & 
Blair, 1996).  Epidemiological studies have shown that a sedentary lifestyle will 
contribute to early onset and progression of CAD and is associated with doubling the 
risk of premature death (Paffenbarger, Hyde, Wing, Lee, Jung & Kampert, 1993).  
Current public health statements recommend physical activity of 30 minutes of 
moderate-intensity activity each day. This provides substantial benefits across a 
broad range of health outcomes for sedentary adults. Individuals performing 30 
minutes of moderate-intensity exercise per day are likely to achieve additional health 
benefits if they exercise more. In addition to aerobic exercise, people should engage 
in resistance training and flexibility exercises at least twice a week, which will 
promote the maintenance of lean body mass and improvements in muscular strength 
and endurance, all of which enable long-term participation in regular physical activity 
and promote quality of life (Blair, Lamont & Nichaman, 2004).  People should be 
advised to choose enjoyable activities which fit into their daily routine, preferably 30 
to 45 minutes, 4 to 5 times weekly at 60-70% of the average maximum heart rate 
(De Backer et al. 2003). 
 
Physically inactive middle aged women experienced a 52% increase all cause 
mortality and a doubling of cardiovascular related mortality (Hu, Willett & Li, 2004).  
Furthermore, it appears that people who are fit and have other risk factors for CVD 
may be at a lower risk of premature death than people who are inactive with no other 
risk factors for CVD (Wessel, Arant, Olson, Johnson, Reis, Sharaf, Shaw, Handberg, 
Sopko, Kelsey, Pepine & Merz 2004). 
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An increase in physical fitness will reduce the risk of premature death and a 
decrease in physical fitness will increase the risk.  The amount of exercise increased 
or decreased appears to have a graded impact on risk. A study conducted by 
Eriksson (2001), demonstrated that participants with the highest levels of physical 
fitness at baseline, who maintained or improved their physical fitness over a 
prolonged period of time had the lowest risk of premature disease.  However, 
modest enhancement in physical fitness, in previously sedentary people has been 
associated with a significant improvement in health status. A study by Myers, 
Prakash, Froelicher, Do, Partington & Atwood (2002) observed that every 1-MET 
(metabolic equivalent task) increase in treadmill performance was associated with a 
12 percent improvement in survival, therefore suggesting that health professionals 
should incorporate promoting physical activity into their practice strategies, in 
addition to the routine treatment of other modifiable risk factors.   
Warburton, Nicol and Bredin (2006) conducted a review of observational studies that 
have been carried out to evaluate the current literature and to provide further insight 
into the role of inactivity in the development of disease and premature death.  The 
review concluded that there is a linear relationship between physical activity and 
health status.  Physical fitness has been associated with cardiovascular mortality 
and even small improvements in fitness may lower mortality (Vanhess, Lefevre, 
Philippaerts, Martens, Huygens, Troosters & Beunen, 2005). 
2.8.3 Dyslipidaemia 
 
Dyslipidaemia means that abnormal levels of lipids are in the body.  These lipids 
include cholesterol and triglycerides.  There are three main lipids of lipoproteins in 
the body: low density lipoproteins (LDL), high density lipoprotein (HDL) and 
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triglycerides.  These are essential for our bodies to function, but elevated lipids can 
contribute to CVD/CHD.  This can be caused by genetic, environmental and lifestyle 
factors. 
 
Elevated LDL contributes to atherosclerosis over a period.  On the other hand, 
having elevated HDL protects the heart by absorbing the build up of LDL from the 
arteries.  Low levels of HDL and triglycerides can contribute to atherosclerosis and 
CHD, especially in people who are obese or have diabetes.  According to the 
National Cholesterol Education Programme Guidelines (2001), healthy adults should 
be screened once every five years starting at age twenty.  Those with a family 
history of hyperlipidaemia or other risk factors may need earlier or more frequent 
screening. 
 
Raised cholesterol has been rated by the World Health Organisation (2002) as the 
leading cause of mortality world wide as it leads to an increased risk of CVD.  
Management of lipids with statins can provide a relative reduction in CVD of around 
30%.  However, Kosteva, Wood, Backer De Bacquer, Pyorala and Keil (2009) argue 
that many patients do not achieve the desirable target on statins alone; lifestyle 
management is an essential element and should not be ignored 
West of Scotland Coronary Prevention Group (WOSCOP) was a randomized clinical 
trial comparing Pravastatin with a placebo, in men aged 45-64 with 
hypercholesterolemia and no history of a cardiac event.  The participants were 
followed up for 5 years and the analysis concluded treatment with Pravastatin was 
associated with significant reduction in coronary events.  Statin treatment for an 
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average of 5 years provided an ongoing reduction in risk for up to 10 years (Ford, 
Murray, Packard, Shepherd, Macfarlene, & Cobbe .2007)  
It has been estimated that every 0.03mmol/l increase in HDL reduces the risk of 
cardiac event by 2% in men and 3% in women (Gordon, Probstfield, Garrison et al. 
1989) 
The INTERHEART study (Yusuf, Hawken, Ounpuu et al. 2004) conducted in 52 
countries investigated the association of risk factors regarding coronary heart 
disease.  15,152 cases and 14,820 controls were enrolled.  The findings suggested 
that the risk factors discussed in this paper, plus diabetes and psychosocial factors 
account for most of the risk of myocardial infarction worldwide in both sexes and in 
all ages.  The study recommended that approaches to prevention can be based on 
similar principles worldwide and have the potential to avert most premature cases of 
CHD. 
2.8.4 Obesity  
Overweight and obesity are defined as abnormal or excessive fat accumulation that 
may lead to serious health consequences.  According to the World Health 
Organisation (2006), there are about 400 million overweight adults worldwide.   The 
fundamental cause of obesity and overweight is an imbalance between calorie 
consumption and expenditure. The Global increase in the prevalence of obesity is 
attributable to a number of factors including increased sedentary lifestyle, modes of 
transportation and increasing urbanization which all lead to decreased physical 
activity.   
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The body mass index (BMI) is a simple tool used to distinguish between overweight 
and obesity in the adult population.  It is defined as the weight in kilograms divided 
by the square of the height in metres (kg/m2). The risk of CVD increases 
progressively as body mass index increases.  Raised body mass index is a major 
risk factor for chronic disease including CVD, which is already the world number one 
cause of death, killing 17 million people each year (World Health Organisation, 
2006). A meta-analysis conducted using data from the prospective studies in the 
South Asian region which integrated 33 cohort studies, including over 300,000 
participants.  It concluded, that was a relationship between high body mass index 
and CVD.  Therefore, decreasing an individual’s BMI would reduce the risk of CVD 
event and every unit of sustained decrease in BMI, HDL increases by 0.02mmol/l 
(Mhurchu, Rodgers, Pan, Gu & woodward, 2004., Berns, de Vries & Kata, 1998) 
Conventional body mass index classifications are: overweight (25.0kg/m2 to 
<30.0kg/m2) and obese (≥30.0kg/m2). These cut off points were derived primarily 
from the European population to represent the thresholds for the risk of CVD.  Due to 
the differential body mass index thresholds relating to ethnicity, the South Asian 
population has had thresholds defined separately to the rest of the population, using 
thresholds of BMI for obesity of 25 kg/m2 for South Asians. The BMI of 23-25 kg/m2 
defines overweight for the South Asian population (WHO, 2004).  The NICE 
guidelines of obesity (2006) dispute this and suggest there is limited evidence that 
for a given BMI morbidity risk in South Asians is higher than the general population.  
However, it recommends that the parameters which have been suggested by WHO 
should generate action for public health. 
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The OXCHECK study was a randomised control trial to assess the effectiveness of 
health checks by nurses in reducing risk factors for cardiovascular disease in 
patients from the general practices. General health checks by nurses are ineffective 
in helping smokers to stop smoking, but they help patients to modify their diet and 
total cholesterol concentration. The public health importance of this dietary change 
depends on whether it is sustained (Muir, Mant, Jones & Yudkin,1994).  Even though 
in this OXCHECK study nurses were ineffective in smoking cessation, the individual 
had access to a service which enabled the individual to make a lifestyle choice. 
 
2.8.5 Blood Pressure and Hypertension 
 
The outcomes of clinical trials have determined the definition of hypertension.  
Hypertension is classified as the level of blood pressure (BP) where evidence implies 
that a reduction of the parameters benefits the individual (Joint British Society 2, 
2005).  The CVD risk associated with blood pressure is determined by both diastolic 
and systolic blood pressure and the presence of other risk factors.  Epidemiological 
studies demonstrate a close relationship between blood pressure and risk of CVD 
and CHD. A meta-analysis suggests that the association between systolic and 
diastolic blood pressure and CVD is more apparent than previously considered 
(Mancia, De Backer, Dominiczak, Cifkova et al. 1990).  
As blood pressure is an independent risk factor, a reduction in BP by 6-12mmHg can 
be estimated to reduce risk of CVD by 40% CHD by 20% (Prospective Studies 
Collaboration, 2002). According to the British Hypertension Society (2004) 
classification of systolic blood pressure of ≥140 -159mmHg and/or diastolic blood 
pressure ≥ 90mmHg is considered to be Grade 1 hypertension (mild).  Lifestyle 
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modification such as, weight reduction, moderation of alcohol, salt intake and 
physical activity has been shown to reduce blood pressure (Berchthold et al 1982, 
Macmohan & Norton 1986).  Long term pharmacological trials have demonstrated 
the benefits of anti hypertensive therapy in reducing the risk of stroke. Therefore, it is 
imperative that lifestyle modification and intervention for example pharmacological 
therapies are initiated earlier. 
 
2.9 Summary 
 
To summarise, damage to the vascular system increases with age and progresses 
faster in men than women, especially in those with a family history of vascular 
disease and of certain ethnic groups.  The rate of vascular damage progression is 
determined by modifiable factors.  Changing these can reduce the probability of 
premature disease. These risk factors are, smoking, physical inactivity, raised blood 
pressure, raised blood cholesterol and obesity which have already been discussed at 
some length. 
Several published guidelines have recommended screening of FDRs.  This would 
involve an assessment of an individuals' risk over ten years (Pearson, Blair, Daniels, 
Eckel, Fair, Fortmann, Franklin, Goldstein, Greenland, Grundy et al. 2002, Chow, 
Pell, Walker, O'Dowd, Dominiczak & Pell 2007).  Studies such as the Heart 
Protection study (Wilmshurst 2002) and numerous other risk factor invention studies 
have shown how effective interventions such as smoking cessation advice, 
dyslipidaemia therapy etc. are in the primary prevention setting. Coupled with the 
fact that the FDRs of patients with premature CVD are a high risk population, it is 
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anticipated that a significant number of events can be avoided by targeted primary 
prevention of this group of individuals. 
 
EUROASPIRE I, II, and III (Kotseva, Wood, De Backer, De Bacquer, Pyorala, & Keil 
(2009) are cross-sectional studies and included the same selected geographical 
areas and hospitals in eight European countries. Patients of both sexes under the 
age of seventy were identified after revascularisation or after a hospital admission 
because of a cardiac event and were interviewed six months later. Over 8,000 
patients were interviewed in the three studies. The results indicated that the 
proportions of patients who smoke have remained virtually the same, but there has 
been an increase in women smokers aged less than 50 years. The occurrence of 
obesity over the three studies has increased by 13%.  The percentage of patients 
with hypertension was comparable, whereas the proportion with raised total 
cholesterol (≥4·5 mmol/L) decreased by 48%. 
  
The EUROACTION (2004) study followed up all patients with heart disease, high risk 
individuals, their partner and FDRs of patients with premature heart disease.  The 
aim of the study was to raise the standards of preventive cardiology in Europe by 
demonstrating that national lifestyles, risk factors and therapeutic goals in CVD 
prevention are achievable and sustainable in everyday clinical practice (Wood, 
Kotseva, Connolly, Jennings et al. 2004).  The EUROACTION preventive cardiology 
programme reduced the risk of CVD, through lifestyle changes by families who 
together made healthier food choices and became more physically active than 
before the intervention. These changes consequently led to some central obesity 
weight reduction in high risk patients.  In a systematic review of ten trials with 
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outcome data, no significant effect on total or coronary mortality was evident 
(Ebrahim, Beswick, Burke & Davey Smith 2006).  However, EUROACTION was 
more effective than usual care because lifestyle intervention was combined with 
cardio-protective drugs that together reduced the CVD event. 
 
Neil, Perera, Armitage, Farmer, Mant and Durrington (2008), describe four steps 
which are involved in disease prevention, these include: 
1. Collection of clinical data: ethnic and socioeconomic determinants of 
health need to be accounted for as part of the cardiovascular risk 
assessment;   
2. The measurement of risk factors; 
3. Interpretation of risk related data; 
4. Intervention to minimise risk disease risk and prevent risk factor 
development.  
The clinician is best positioned to interpret and integrate the collected data and 
therefore needs to be familiar with all its limitations (Vuljoen 2008). 
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Chapter 3 Methods 
 
Primary prevention refers to interventions designed to educate and modify risk 
factors in individuals who have not yet been diagnosed with CHD. The risk of 
developing heart disease can be minimised by using two broad strategies, firstly to 
try to reduce the prevalence of heart disease within the entire population.  The 
second important element of primary prevention is identifying and supporting those 
individuals at high cardiovascular risk.  In most parts of the United Kingdom current 
services in both primary and secondary care neglect targeted risk assessment and 
primary prevention of CVD in FDRs of patients with proven premature CHD (Patel, 
Minhas,  Lincoln & Dhillon 2008).    
In line with the Department of Health (2000), primary prevention of CHD should be 
targeted at people with high overall risk and FDR’s of patients with premature CHD 
who are at higher risk than the general population.  Premature CHD was defined as 
below the age of 55 years in men and 60 years in women so relatives of patients 
with premature onset are at a greater risk than those of patients with late onset of 
disease. 
 
3.1   Ethical Approval  
 
Ethical approval to conduct this study was granted on the 4th August 2008 from the 
Ethical Committee (appendix 1) and the Research and Development department at 
Sandwell Hospital (appendix 2). Verbal consent was gained from the index case 
during their admission to contact their FDRs (as part of standard NHS care) and 
FDRs gave written consent at their first hospital visit (appendix 3). 
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Participants 
 
Total of 43 Participants, both female and male aged from 18 -74 years old were 
involved in the study.  The study was carried out at the Outpatient Department at 
Sandwell Hospital, which consisted of one cohort of FDRs.  The sample population 
included all FDRs seen over a period of 6 months on two occasions in the primary 
prevention service.  
 
3.2 Inclusion and exclusion criteria 
 
Inclusion criteria 
• FDR of patients with proven coronary heart disease. 
• Index cases were men under the age 60 and women under the age of 65. 
Exclusion Criteria 
• Individuals with dementia 
• Under the age of18  
• Over the age of 75 
• Individual declining participation in the primary prevention service 
 
3.3  Procedure 
 
For the purposes of this study, premature CHD was defined as below the age of 60 
years in males and below the age of 65 years in females. Index cases were deemed 
to have established and proven CHD by virtue of a diagnosis of acute coronary 
syndrome (including myocardial infarction) and /or requiring coronary angioplasty or 
bypass surgery on acute admission to hospital. These index cases were identified on 
a daily basis by the cardiac rehabilitation nursing staff at an acute trust in Sandwell 
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and West Birmingham. During structured delivery of phase 1 of cardiac rehabilitation, 
Index cases were invited to participate in the study following direct discussion and 
informed consent by a specialist nurse. Index cases were therefore consented to 
analysis of their own CV risk factors and also agreed to invite their FDR to a primary 
prevention service established to support this cohort of FDR. Therefore, direct 
contact with FDR was not made. Access to primary prevention was offered either in 
the acute hospital clinic or in primary care with their own GP or a nurse led 
community service. Only individuals accessing the secondary care service were 
assessed in this study. 
 
Index Cases underwent conventional cardiovascular risk assessment as part of 
Phase 1 of cardiac rehabilitation which included documentation of and where 
necessary interventions in terms of both behavioural advice, access to lifestyle 
services or therapeutic interventions for  smoking status, obesity, dyslipidaemia, 
physical (in)activity, hypertension and diabetic status. During phase 1 assessment, a 
detailed family history would be obtained to identify the number of FDR at risk of 
CVD.  Index cases were then provided invitation letters (appendix 4) and information 
sheets (appendix 5) to cascade to their FDRs. 
 
The FDR would then contact the cardiac rehabilitation team administrator and a 
member of the cardiac rehabilitation team nursing staff provided an explanation of 
the service offered. The FDR was able to access primary prevention in either primary 
or secondary care.  If acceptable, an appointment was made and a request form to 
have blood tests taken for full blood count, full lipid profile, renal and liver 
biochemistry and blood glucose. This enabled results to be available at the time of 
clinic visit.  
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The FDR, at appointment underwent cardiovascular risk assessment and received 
advice and interventions as necessary from the researcher. Therapeutic 
interventions were guided by guidelines from the National Institute for Health and 
Clinical Excellence (NICE, 2008) following cardiovascular risk assessment using the 
modified Framingham equation also advocated by NICE (2008). If a FDR declined 
initial referral to lifestyle risk management services for example smoking cessation, 
they were given contact numbers to access the service at a later date if required. 
 
 
Prior to the consultation the health care assistant would record the height and weight 
of the FDRs this was recorded in their medical notes.  At the first consultation the 
subject was 
• Given verbal information about the consultation.  
• Given written information and consent form regarding the study.   
• Informed that they may withdraw from the study at anytime and this would 
not impact on any future treatment. 
• During consultation the FDR was given information regarding CVD risk in 
line with NICE guidelines lipid modification (2008)(Glick,2000) 
 
3.4   Smoking Status 
 
The smoking status of FDR was ascertained, European guidelines (2003) emphasise 
that smoking status must be addressed and documented by health professionals.  
(Manso, Tosteson, Ricler et al 1992)  
 
 
• Advice and written literature given regarding the benefits of stopping   
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• Offer nicotine replacement patches 
• Referred to smoking cessation service. 
 
The above intervention is in line with the NICE guidelines for Smoking Cessation 
(2007). 
 
3.5   Body mass index  
 
Lending from the literature, the parameters for body mass index were set according 
to the World Health Organisation (2004) and NICE guidelines for obesity (2006). The 
weight was recorded using the Avery E101 serial number 00002047 scales.  Height 
measured using Seca wall mounted metre.  The intervention below is based on 
recommendation by Department of Health, (2000) and the Health Checks 
Programme (2008): 
• Ascertain current eating habits and offer written literature;   
• Refer to dietician or weight management team for further support; 
• Initiate medical therapy if BMI >40Kg/m2; 
• Refer to GP to initiate medical therapy. 
 
3.6 Blood cholesterol 
 
A blood Sample was taken prior to clinic appointment. These would be analysed 
within the Pathology Department at the hospital to ascertain cholesterol profile renal 
and liver biochemistry. Depending upon the lipid profile and calculated CVD risk, the 
intervention was either: 
• Written information to improve dietary intake;  
• Medical therapy was initiated and a written prescription was given to the 
individual if clinically indicated. 
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The above intervention is supported by the NICE guidelines for Lipid modification 
(2008). 
 
3.7 Blood pressure and hypertension 
 
Blood pressure was measured according to the guidelines recommended by  
Mancia, De Backer, Dominiczak, Cifkova, Fagard, Germano et al. (2007). The FDRs 
were informed of their blood pressure reading.  Blood pressure was measured using 
an OMRON electronic blood pressure monitor which meets the British Hypertension 
Society (2004).   
• According to the BHS (2004) recommendation standard and large adult cuff 
sizes were used; 
• The blood pressure was repeated if the diastolic was 90mmHg or more, or if 
the systolic pressure was 160mmHg or more and the lowest of the two 
readings were recorded;  
•  Medical therapy would be initiated by the Consultant if indicated prior to 
discharge from clinic; 
• If blood pressure was above the recommended target they were advised to be 
reviewed by the General Practitioner or Practice Nurse. 
If therapeutic intervention was required the guiding recommendations stipulated by 
NICE (2006) were adhered to. 
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3.8 Cardiovascular calculators 
 
A number of models for coronary heart disease and cardiovascular risk calculators 
have been developed and for the purposes of this research the following calculators 
were used:-  
1. QRISK II, - this was developed from routinely collected data from the general 
practice clinical computer systems. The algorithm uses existing risk factors, smoking 
status, lipid profile, age, blood pressure but also incorporates deprivation and 
ethnicity  (Hippisley-Cox, Coupland, Vinogradova, Robson, Minhas, Sheik & Brindle, 
2008). 
2. FRAMINGHAM – Calculates the absolute risk of coronary heart disease event for 
patients with no previous history of coronary heart disease, stroke and peripheral 
vascular disease (Sheridan, Pignone & Mulrow 2003).    
3. ETHRISK - Ethnic groups within Britain have differing risks of coronary heart 
disease and CVD at the same level of risk factors. This calculator adjusts for 
ethnicity and is based on a re-calibration of the Framingham risk equations.  It also 
provides the standard Framingham estimates.  The method uses the prevalence 
ratios for coronary heart disease and CVD for each ethnic group compared to the 
general population, and adjusts for differences in mean risk factor levels and 
prevalence of smoking between each ethnic group (Brindle, May, Gill, Cappuccio, 
D’Agostino, Fischbacher & Ebrahim 2006). 
4. Modified Framingham – this method involves prior estimate of cardiovascular 
risk.  This is derived from risk factors data that are routinely held in electronic 
medical records with unknown blood pressure and /or cholesterol levels replaced by 
default values derived from the national survey data (Marshall, 2008) 
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3.9   Method of data collection 
 
Data was collected on two occasions, on their first appointment then six months later 
at their review appointment.  All the data was entered onto an Excel spreadsheet 
which was password protected. The FDR identified goals which needed to be 
achieved prior to their next appointment (appendix 6).  The FDR was then reviewed 
in clinic six months later to assess the impact of the service and discuss any 
concerns they may have had (NICE, 2008). 
 
3.10   Method of data analysis 
 
Appropriate descriptive statistics were calculated for each variable following a check 
of normality using the Shapiro-Wilk statistic (Coakes & Steed, 2004).  The mean and 
standard deviation for each variable was calculated for each variable.  All data was 
analysed using SPSS (version 16.0) and the significance level was set at 0.05. 
 
The assumption of normal distribution homogeneity was violated for each variable.  
The data was ordinal consequently a non-parametric approach. The Wilcoxan signed 
rank test was used to analyse the data because the participants were seen on two 
occasions and the same tests were repeated. The mean and standard deviation for 
each variable was calculated.  
 
 
 
Chapter 4: Results 
Ranjit Kaur Dhillon 36
Chapter 4: Results 
 
A total of 463 letters were given to 201 patients who accessed the Coronary care 
unit. 113 (24%) FDR accessed the service since September 2008 – June 2009. Only 
43(44%) were eligible, 57% were not eligible because they failed to attend the clinic 
on two occasions or they were still waiting for their review to take place. 
 
4.1 Basic Demographic data 
 
The following results are based on FDRs who attended both first and review 
appointments. The information was gathered at their first appointment at the Primary 
Prevention Service. 
4.1. Illustrates demography of the FDRs 
 
 
List of Variables 
 
Value 
Mean Age (years) 42 
Males (%) 44 
Females (%) 56 
South Asian (%) 63 
Non-South Asian (%) 37 
 
Table 4.1: Demography of subjects 
 
The table shows the mean age of the FDRs was 42 years.  44% (19) were male and 
56%(24) were female.  63%(27) were south Asians and 37% (16) were non south 
Asians 
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4.2 Summary of results 
4.2.1 Dependent and independent variables 
 
DEPENDENT 
VARIABLES 
BASELINE REVIEW  
 
PERCENTAGE 
CHANGE 
P 
VALUE
Systolic Blood Pressure (mmHg) 140(±14.8)  137 (±4.94) -2 0.56 
Diastolic Blood Pressure (mmHg) 94(±2.12)  92 (±11.31 -2 0.58 
Total Cholesterol (mmol\l) 7.1(±1.8) 6.1(±0.56). -7.4 0.34 
High Density Lipoprotein males 
(mmol\l) 
1.2(±0.2) 1.1(±0.1) -8 0.31 
High Density Lipoprotein females 
(mmol\l) 
1.4(±1) 1.3(±0) -8 0.31 
Triglycerides (mmol\l) 2.75(±0.49 2.45(±0.49) -11 0.41 
Body mass index (Kg/m2) 
South Asians 
 
31(±0) 
 
31(±1.8) 
 
0 
 
0.09 
Body mass index (Kg/m2) 
Non South Asians 
 
27(±1) 
 
26(±2.8) 
 
-3 
 
0.08 
 
Table 4.2: Summary of results for all dependent and independent variables measured 
at baseline and review appointments for First Degree Relatives (n=43). 
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4.2.2 CV risk scores 
 
DEPENDENT 
VARIABLES 
BASELINE REVIEW  
 
PERCENTAGE 
CHANGE 
P 
VALUE
QRISK (%) 7.5(±6.4) 6(±5.6) -20 0.31 
ETHRISK CVD (%) 14.5(±9.1 7.5(±7) -48 0.1 
ETHRISK CHD (%) 12.5(±6.3) 6.5(±6.3) -48 0.1 
FRAMINGHAM BNF (%) 12.4(±12.1) 7.3(±6.7)) -41 0.68 
FRAMINGHAM CVD (%) 14.8(±14.2) 8.3(±6.57) -43 0.04* 
FRAMINGHAM CHD (%) 10.5(±10.5) 6(±5.5) -43 0.31 
MODIFIED FRAMINGHAM 18.5(±23.3) 9.5(±4.9) -48 0.0.2* 
*denotes significant difference p<0.05 
Table 4.3: CV Risk Scores in First Degree Relatives (n=43) 
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4.2.3 Gender and age distribution 
Gender & Age Distribution
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Figure 4.1:  Distribution of gender and age of First Degree Relatives (n=43) 
 
The mean age of the FDRs was 42 (±4.24 years).   
56% (n=24) of FDRs were females and 44% (n=19) were males. 
66% (n=28) of patients who accessed the service were less than 40 year old.  
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4.3.4 Systolic blood pressure measurement 
 
 
Figure 4.2:  Systolic Blood Pressure (SBP) of First Degree Relatives 
At the baseline appointment 30% (n=13)of FDRs had a systolic blood pressure 
greater than 140mmHg and 70% l(30) less than 139mmHg. The mean SBP of FDRs 
was at 140(±14.8) mmHg. 
At the review appointment 26% (n=11) of FDRs had a systolic blood pressure 
greater than 140mmHg and 74% (n=32) less than 139mmHg. The mean was 137 
(±4.94) mmHg. 
A Wilcoxon test revealed that these differences were not statistically significant 
(p=0.56). 
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4.2.5   Diastolic blood pressure measurement 
 
 
Figure 4.3:  Diastolic Blood Pressure of First Degree Relatives 
At the baseline appointment 28% (n=28) of FDRs had a diastolic blood pressure 
greater than 90mmHg and 72% (n=31) less than 90mmHg. The mean DBP of FDRs 
was at 94(±2.12) mmHg. 
At the review appointment 14% (n=6) of FDRs had a diastolic blood pressure greater 
than 90mmHg and 86% (n=37) was less than 90mmHg. The mean was 92 (±11.31) 
mmHg. 
A Wilcoxon test revealed that these differences were not statistically significant (p= 
0.58) 
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4.2.6   South Asian body mass index 
 
 
Figure 4.4:  Distribution of Body Mass Index of  
First Degree Relatives in South Asians 
 
18% (n=8) of FDRs of South Asian background at first appointment had a BMI less 
than 23 Kg/m2.  82% (n=35) of FDR had a BMI greater than 23 Kg/m2.   
 
26% (n=11) of FDRs South Asian background at review appointment had a BMI less 
than 23 Kg/m2.  74% (n=32) of FDRs had a BMI greater than 23 Kg/m2.   
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4.2.7   Non-South Asian body mass index 
 
 
Figure 4.5:  Distribution of Body Mass Index of  
First Degree Relatives in Non South Asians 
 
38% (n=16) of FDRs of non-South Asian background at first appointment had a BMI 
less than 25 Kg/m2.  63% (n=27) of FDRs had a BMI greater than 25 Kg/m2.   
 
44% (n=19) of FDRs non-South Asian at review appointment had a BMI less than 25 
Kg/m2.  50% (n=22) of FDRs had a BMI greater than 25 Kg/m2.   
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4.2.8 Distribution of high density lipoproteins in males 
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Figure 4.6:  Distribution High Density Lipoprotein of First Degree Relatives in males 
 
In 11% (n=5) of male FDRs HDL had less than 1.0 mmol/l and 89% (n=38) greater 
than1.0 mmol/l at baseline appointment.  The mean was 1.2 (±0.2) mmol/l. 
 
6% (n=3) of male FDRs had HDL less than 1.0 mmol/l and 94% (n=40) greater 
than1.0 mmol/l at their review appointment.  The mean was 1.1 (±0.1) mmol/l. 
A Wilcoxon test revealed that these differences were not statistically significant.  
(p=0.31) 
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4.2.9   Distribution of high density lipoproteins in females 
 
Distribution High Density Lipoprotein (HDL) in 
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Figure 4.7:  Distribution High Density Lipoprotein of First Degree Relatives in females 
 
4% (n=2) of females FDRs had HDL less than 1.2mmol/l and 96% (n=41) greater 
than1.2mmol/l at baseline appointment.  The mean was 1.4(±1) mmol/l.  16% (n=7)of 
females FDR had HDL less than 1.2mmol/l and 84% (n=36) greater than1.2mmol/l at 
their review appointment.  The mean was 1.3(±0) mmol/l. 
A Wilcoxon test revealed that these differences were not statistically significant 
(p=0.31). 
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4.2.10   Distribution of cholesterol levels 
 
 
Figure 4.8: Distribution of Total Cholesterol of the population 
 
37% (n=16) of FDRs had total cholesterol less than 5mmol/l and 61% (n=26) of FDR 
had total cholesterol greater than 5mmol/l but less than 7.5mmol/l. 2% (n=1) of FDRs 
at their baseline appointment had a total cholesterol greater than 7.5mmol/l.  The 
mean of the total cholesterol was 7.1(±1.8) mmol/l. 
 
54% (n=23) of FDRs had total cholesterol less than 5mmol/l and 44% (n=19) had 
total cholesterol greater than 5mmol/l but less than 7.5mmol/l. 2% (n=1)of the FDRs 
had a total cholesterol greater than 7.5mmol/l. The mean of the total cholesterol was 
6.1(±0.56) mmol/l. 
A Wilcoxon test revealed that these differences were not statistically significant 
p=0.34 (not significant). 
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4.2.11   Distribution of triglycerides 
 
Distribution of Triglycerides in First Degree Relatives
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Figure 4.9: Distribution of Triglycerides in first degree relatives 
 
In 64% (n=28) of FDRs triglycerides were less than 2.0mmol/l and 36% (n=15) 
greater than 2.0mmol/l at baseline appointment.  The mean of the triglycerides was 
2.75(±0.49) mmol/l. 
 
In 68% (n=29) of FDRs triglycerides were less than 2.0mmol/l and 32% (n=14) 
greater than 2.0mmol/l at their review appointment.  The mean of the triglycerides 
was 2.45(±0.49) mmol/l.  
 
A Wilcoxon test revealed that these differences were not statistically significant.  
(p=0.41) 
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4.2.12   Cardiovascular risk using QRISK 
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Figure 4.10:  Cardiovascular tool QRISK 
 
77% (n=33) of FDRs were low risk, 9% (n=4) medium risk and 14% (n=6) high risk at 
baseline appointment. The mean was 7.5(±6.4) %. 
 
84% (n=36) of FDRs were low risk, 2% (n=1) medium risk, 14% (n=6) high risk at 
their review appointment.  The mean was 6(±5.6) %. 
A Wilcoxon test revealed that these differences were not statistically significant 
(p=0.31).  
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4.2.13   Cardiovascular risk using ETHRISK CVD 
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Figure 4.11:  Cardiovascular calculator ETHRISK CVD 
 
81% (n=35) of FDRs were low risk, 5% (n=2) medium risk and 14% (n=6) high risk at 
baseline appointment. The mean of the Cardiovascular calculator ETHRISK CVD 
was 14.5(±9.1) %.  
 
88% (n=38) of FDRs were low risk, 2% (n=1) medium risk, 9% (n=4) high risk at their 
review appointment.  The mean of the Cardiovascular calculator ETHRISK CVD was 
7.5(±7) %. 
A Wilcoxon test revealed that these differences were not statistically significant 
(p=0.10).  
 
 
Chapter 4: Results 
Ranjit Kaur Dhillon 50
4.2.14   Cardiovascular risk using ETHRISK CHD 
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Figure 4.12:  Cardiovascular calculator ETHRISK CHD 
 
86% (n=37) of FDRs were low risk, 12% (n=5)medium risk and 2% (n=1) high risk at 
baseline appointment. The mean of the Cardiovascular calculator ETHRISK CHD 
was 12.5(±6.3)%. 
 
93% (n=40) of FDRs were low risk, 5% (n=2) medium risk, 2% (n=1) high risk at their 
review appointment.  The mean of the Cardiovascular calculator ETHRISK CHD was 
6.5(±6.3)%. 
A Wilcoxon test revealed that these differences were not statistically significant 
(p=0.10). 
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4.2.15   Cardiovascular risk using Framingham BNF 
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Figure 4.13:  Cardiovascular calculator Framingham BNF 
 
86% (n=37) of FDRs were low risk, 7% (n=3) medium risk and 7% (n=3) high risk at 
baseline appointment. The mean of the Cardiovascular calculator Framingham BNF 
was 12.4(±12.1) %. 
 
98% (n=42) of FDRs were low risk, 0% medium risk, 2% (n=1) high risk at their 
review appointment.  The mean Cardiovascular calculator Framingham BNF was 
7.3(±6.7)%. 
A Wilcoxon test revealed that these differences were not statistically significant 
(p=0.68). 
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4.2.16   Cardiovascular risk using Framingham CVD 
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Figure 4.14:  Cardiovascular calculator Framingham CVD 
 
86% (n=37) of FDRs were low risk, 2% (n=1) medium risk and 12% (n=5) high risk at 
baseline appointment. The Cardiovascular calculator Framingham CVD mean was 
14.8(±14.2) %.  
 
88% (n=38) of FDRs were low risk, 7% (n=3) medium risk, 5% (n=2) high risk at their 
review appointment.  The mean of the cardiovascular calculator Framingham CVD 
was 8.3(±6.5) %. 
A Wilcoxon test revealed that these differences were statistically significant 
(p=0.046). 
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4.2.17   Cardiovascular risk using Framingham CHD 
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Figure 4.15:  Cardiovascular calculator Framingham CHD 
 
93% (n=40) of FDRs were low risk, 7% (n=3) medium risk and 0% high risk at 
baseline appointment.  The mean of the cardiovascular calculator Framingham CHD 
was 10.5(±10.5) %.  
 
98% (n=42) of FDRs were low risk, 2% (n=1) medium risk, 0% high risk at their 
review appointment.  The mean of the cardiovascular calculator Framingham CHD 
was 6(±5.5) %. 
A Wilcoxon test revealed that these differences were not statistically significant 
(p=0.317). 
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Cardiovascular Risk using Marshall
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Figure: 4.16.  Cardiovascular calculator Modified Framingham 
 
70% (n=30) of FDR were low risk, 9% (n=4) medium risk and 21% (n=9) high risk at 
base appointment. The mean of the Modified Framingham was 18.5(±23.3) %  
 
79% (n=34) of FDR were low risk, 9% (n=4) medium risk, 12% (n=5) high risk at their 
review appointment.  The mean of the Modified Framingham was 9.5(±4.9) % 
A Wilcoxon test revealed that these differences were statistically significant (P= 0.02) 
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4.2.19   Referral to specialist services 
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Figure 4.16:  Intervention during Primary Prevention Service 
 
14% (n=6) of FDRs were referred for other investigations. 21% (n=9) were 
commenced on medication or medication was altered.  12% (n=9) of smokers were 
referred to a smoking cessation clinic.  25% (n=11) were referred to a weight 
management service.  32% (n=14) were referred to Consultant Cardiologist or 
Lipidologist.  19% referred to exercise on prescription. 
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Chapter 5 – Discussion 
 
This study, attempts to evaluate a FDRs screening programme to identify those at 
cardiovascular risk and support the concept that a prevention and intervention 
programme can be effectively implemented in the acute sector.  The objective of the 
FDRs study was to identify and assess cardiovascular risk of FDRs with proven 
CHD.  Furthermore, we assessed the effectiveness of cardiovascular risk reduction 
services on the individual.  
 
Since 85% of CV risk is modifiable and premature CHD constitutes a significant 
burden of morbidity and mortality in England, it is prudent to reduce lifetime risk by 
targeted primary prevention in high risk populations such as FDR, many of whom 
would not be able to access conventional Health Checks in England. Delivery of a 
service which systematically identifies and offers primary prevention to FDR of 
patients with documented premature CHD, such as this one discussed, would enable 
complementary strategies to address absolute risk and lifetime risk to be delivered in 
tandem.  
 
Demographics 
The FDR who accessed the service were younger 40 years of age (66%) (figure 
4.1), suggesting the younger FDR are more motivated and took up the opportunity to 
modify their cardiovascular risk.  However, the service was predominately accessed 
by female (56%) and south Asians (63%) (Table 4.1).  This study identified risk 
factors in individuals who would not conventionally be accessed by the NHS Health 
Checks programme. It could be argued that the age criteria of the National 
Programme should be lowered to include FDR’s under the age of 40. It could also be 
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recommended that this service could be seen as complementary to NHS Health 
checks.  South Asians group are considered to be hard to reach groups.   For this 
study the majority of FDR that accessed the service were from a south Asian 
background.  In addition the Joint British Society 2 (2005), suggests that 
asymptomatic people should have an opportunistic cardiovascular risk check over 
the age 0f 40.  But also recognises that younger people will be at low total risk over 
the short term, although they may be at very high risk relative to peers of the same 
age.  
 
The primary objective of this study was to identify and assess FDRs which was 
successful and consequently the hypothesis (H1) that FDR can be identified by 
proactive case finding was substantiated.  This enables the recommendations in 
Joint British Society 2 guidelines, that FDR should always be screened for 
cardiovascular risk if they have a strong family history of CVD. As discussed earlier, 
Eaton et al (1996) suggested that there is a threefold increase risk of developing 
premature CVD when any FDRs was affected and sixfold increase when FDR 
developed CVD before the age of 45 years.  
 
Both the Joint British Society 2 (2005), Department of Health, (2000) and the task 
force define family history of premature CHD men <55 and women <65.  For the 
purpose of this study the author recruited men <60 and women <65, this enabled the 
researcher to capture a larger cohort.   
 
The second objective of the study was to identify FDRs of patients with proven CHD, 
this was effectively accomplished as results clearly illustrate.  This cohort of young 
high risk individuals would not conventionally be accessed by the NHS Health 
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Checks programme. Hence, demonstrates the benefits of providing a tailored service 
for young individuals potentially high risk and susceptible to premature CVD. 53% of 
the FDR accessing the service were under the age of 40years. This population 
would not be able to access the systematic Health Checks programme provided by 
the National Health Service.  This study is supported by research conducted by 
Bertuzzi et al. (2003) suggesting that family history of ischemic heart disease is an 
independent risk factor and correlation between early onset of CHD and family 
history is evident therefore early intervention and management is imperative.    
Systolic and Diastolic Blood Pressure  
30% of FDR’s at their baseline appointment had a systolic blood pressure greater 
than 140mmHg (figure 4.2).  The Wilcoxon signed rank test showed there was no 
significant difference (p=0.56) between baseline and review visit.  However, the 
cohort of FDRs’ demonstrated a percentage change -2% reduction in systolic blood 
pressure reading.   
Figure 4.3 illustrates that diastolic blood pressure showed a percentage change -2% 
improvement over a period of 6 months even though these differences were not 
significant (p=0.56). It can be argued that primary prevention intervention has an 
impact on the FDRs lifestyle choices.  The objective of the study regarding blood 
pressure has been achieved and the null hypotheses can be rejected, because 
cardiovascular tools were able to risk stratify as, low, medium and high.  The 
literature supports the parameters used in this study regarding systolic and diastolic 
(British Hypertension Society, 2004 and, Joint British Society 2 005).  The result of 
this study is dissimilar to the EUROASPIRE I, II, &III (2009), which demonstrated no 
change in blood pressure, but emphasises the compelling need for more effective 
lifestyle management which this study exemplifies. It could be recommended that the 
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time frame this study was to short and perhaps similar to EUROSPIRE study it could 
extended for a number of years. 
The results of this study mirror the Euroaction (2008) study discussed earlier.    
However, the main variation is that the Euroaction study consisted of a 
physiotherapist and dietician.  The relatives were invited to attend a particular group 
every week to address the risk factor and behavioural modification.  It could be 
recommended that the service model of this study and elements of the Euroaction 
study (2008) could expand into the existing cardiac rehabilitation programme and 
provide an entire programme under one speciality.   
Body mass index 
In terms of body mass index differences between the south Asians (Figure 4.4) and 
non south Asians (Figure: 4.5) levels of obesity were high in both populations.  In the 
non south Asians 63% were considered to be overweight or obese and at the review 
appointment 40% were categorised overweight or obese the overall percentage 
change was -3%.  In south Asians 82% of FDR had a BMI >23kg/m2 at baseline 
appointment and the review it was 64% the overall percentage rate indicated no 
change. Taken as a whole cohort 25% were referred to weight management services 
19% were referred to exercise on prescription to assist in weight management and to 
reduce their CVD risk (figure: 4.14). However, it’s unclear whether the FDR engaged 
with the weight management or the exercise on prescription service at baseline or at 
review.  This would suggest that interventions to tackle the obesity epidemic are 
warranted at a general population level but should perhaps be reinforced and 
tailored to address obesity in the high risk south Asian population, where premature 
CHD occurs at a significantly younger age than for other populations and results in a 
greater socioeconomic impact at the level of the family unit as well as the overall 
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economy by virtue of increasing potential years of life lost and increased disability 
adjusted life years.   The studies discussed in Chapter 2, highlight that sedentary 
lifestyle is a predisposing factor to obesity.  This study enabled FDRs to access 
services to improve their physical activity the finding of the study conducted Eriksson 
(1998) demonstrated that those that maintained physical fitness reduced CVD risk.  
Future recommendations for this study that FDRs referred to exercise on prescription 
need to be followed up to for a longer period to establish whether exercise actually 
reduced their BMI levels.  Waist circumference also could be measured to define 
obesity as Joint British Society guidelines (2005) and Department of Health (2008) 
Health programme have recommended. 
Dyslipidaemia 
 
11% of males had an HDL less than 1.0mmol\l, 89% was over 1.0mmol/l at baseline 
appointment. At the review appointment 6% of males had an HDL less than 
1.0mmol\l, 94% was over 1.0mmol/l at baseline appointment The overall percentage 
change was -8% from a mean of 1.2mmol/l to 1.1mmol/l (table 4.2).   Although, this 
demonstrates an improvement (Figure: 4.6.), these differences were not statistically 
significant (p=0.31). 
 
In the females the results illustrates a contrasting trend (Figure: 4.7) 4% of females 
HDL was less than 1.0mmol\l, 96% was over 1.0mmol/l at the baseline appointment.  
At the review appointment this showed, 16 % of females HDL was less than 
1.0mmol\l; 84% was over 1.0mmol/l. Consequently, there has been an opposite 
impact on the findings. The overall percentage shows -8 from a mean 1.4mmol/l to 
1.3mmol/l, but these differences were not statistically significant (p=0.31). 
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61% of FDRs cholesterol was between the level of 5-7.5mmol/l (figure: 4.8) at review 
appointment his level was reduced to 44%.  Overall, table 4.2, shows a percentage 
change of -7.4%, although this was not statically significant it shows a positive shift 
towards cholesterol reduction.  Similar results were apparent with the triglycerides 
(figure: 4.9.).  At baseline, 64% had triglycerides less than 2mml/l at review 68% had 
triglycerides less than 2mml/l, demonstrating percentage change -11% (table 2) from 
a mean of 2.75mmol/l to 2.45mmol/l.  Figure 4.16, exemplifies that 21% of the FDRs 
where commenced on medication or there current medication was optimized.  
However, it is indistinguishable whether FDR were commenced on medication during 
baseline or review appointment.  Recommendation for future study could include 
collecting data regarding when the intervention was first commenced and follow the 
FDR to observe whether lifestyle or pharmacological intervention actually reduced 
CVD risk. The INTERHEART study (Yusuf et al, 2004) identified cholesterol as a risk 
factor associated with CHD.  The study was a large study performed in 52 countries 
simultaneously.  The FDRs study could be extended into varies acute sectors 
throughout England, recruiting FDRs from the age of 18 years and the collect data 
which actually reflects the population of England. The Euroaction study (2008), to a 
degree performs this however, the index cases were less than 80 years whereas in 
this study the age was younger for proven CHD, the Framingham study concluded 
that life time risk was greater in men aged 40 years.  It would also have been of 
benefit to identify FDR with low HDL and to distinguish whether they were referred to 
exercise on prescription and repeat blood sample to see whether their HDL had 
improved.  Research discussed earlier suggested that HDL increase with physical 
activity within a year of commencing moderate exercise.  
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Cardiovascular risk predication tools 
 
QRISK tool (figure 4.10) identified 77% of FDRs as low risk, 9% at medium risk and 
14% at high risk at baseline.  At the review appointment 84% were categorised as 
low risk, 2% medium risk and 14% high risk. Overall, table 4.3 shows percentage 
change of -20%, from a mean of 7.5% to 6%, but this difference was not statically 
significant (p=0.31).  
 
ETHRISK CVD (figure 4.11) calculated 81% as low risk, 5% medium risk and 14% 
high risk at baseline.  At the review appointment 88% calculated as low risk, 2% 
medium risk and 9% high risk.  Overall, table 4.3 shows percentage change of -48%, 
from a mean of 14.5% to 7.5%, but this difference was not statically significant 
(p=0.1).  
 
ETHRISK CHD (figure 4.12) calculated 88% as low risk, 12% medium risk and 2% 
high risk at baseline.  At the review appointment 93% calculated as low risk, 5% 
medium risk and 2% high risk.  Table 4.3, shows percentage change of -48%, from a 
mean of 12.5% to 6.5%, but this difference was not statically significant (p=0.1).   
 
Framingham BNF (figure 4.13) calculated 86% as low risk, 7% medium risk and 7% 
high risk at baseline.  At the review appointment 98% calculated as low risk, 0% 
medium risk and 2% high risk.  Overall, table 4.3 shows percentage change of -41%, 
from a mean of 12.4% to 7.3%, but this difference was not statically significant 
(p=0.68) 
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Framingham CVD (figure.4.14) calculated 86% as low risk, 2% medium risk and 12% 
high risk at baseline.  At the review appointment 88% calculated as low risk, 7% 
medium risk and 5% high risk.  Overall, table 4.3 shows percentage change of -43%, 
from a mean of 14.8% to 8.3%, but this difference was not statically significant. 
(p=0.04) 
 
Framingham CHD (figure 4.15) calculated 93% as low risk, 7% medium risk and 0% 
high risk at baseline.  At the review appointment 98% calculated as low risk, 2% 
medium risk and 0% high risk.  Overall, table 4.3 shows percentage change of -43%, 
from a mean of 10.5% to 6%, but this difference was not statically significant 
(p=0.317). 
 
Modified Framingham (figure 4.16) calculated 70% as low risk, 9% medium risk and 
21% high risk at baseline.  At the review appointment 79% calculated as low risk, 9% 
medium risk and 12% high risk.  Overall, table 4.3 shows percentage change of -
43%, from a mean of 23.3% to 4.9%, but this difference was statically significant 
(p=0.02). 
 
All the tools accessed were able to risk stratify FDRs if they were over a particular 
age, but the age criteria for each tool was different.  The QRISK (Hippisley-Cox et al. 
2008) and ETHRISK (Brindle et al. 2006) age criteria was 35-74 years of age, 
Framingham BNF, CHD, CVD (Joint British Society, 2005)  is 30-75 years of age and 
for the Modified Framingham (Marshall, 2008)  age from 18 years of age.  For the 
benefit of the study those that were under the age 30, modified Framingham was 
able to communicate risk to the FDR over the age 18 especially if they possessed all 
three risk factor Dyslipidaemia, hypertension and was smoker.  The calculator was 
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adjusted according to age and risk factor changed to show the FDR how lifestyle 
modification could reduce the impact of CVD.  In this study at the review 
appointment the calculator was used again to assess risk, it evident in the guidelines 
discussed that once treatment has been commenced tool should be used again to 
illustrate CVD risk (Joint British Guidelines, 2005., Department of Health Health 
Checks Programme, 2008).  However the FDR were informed of this, but still sought 
to observe if their risk had decreased. As Goodyear-Smith et al (2008) suggest 
calculating risk is not a unilateral decision but decision which shared between 
clinician and individual. For the purpose of this study, the risk calculated and 
communicated to the FDRs was based on the Modified Framingham as the NICE 
lipid modification guidelines (2008). 
Primary prevention service 
 
 
14% of FDRs were referred for other investigations. 21% were commenced on 
medication or medication was altered.  12% of smokers were referred to a smoking 
cessation clinic.  25% were referred to a weight management service.  32% were 
referred to Consultant Cardiologist or Lipidologist.  19% referred to exercise on 
prescription.  With this service the FDRs had access to lifestyle risk management 
services which they were able to access at time of appointment whether at baseline 
or review.  32% had to be reviewed by the cardiologist or lipidologist and further 
investigations were initiated.  It can be suggested these individual would not have 
had access to a specialist service at such early age if they never took the initiative to 
contact the researcher. As proposed previously it is only the motivated FDRs that 
actually access the service.  However a limitation to the study is that those that had 
investigation performed the outcomes of these were not collated, future 
recommendation would be gather the data. Furthermore, when collecting the data it 
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would have been useful to have categorised which speciality the FDR was referred 
to.   
Summary 
Overall, this evaluation demonstrates how one might establish a service to identify 
individuals with significant risk factors for CHD at a young age by taking advantage 
of an opportunity when these families might be a more captive audience at the time 
of an acute event in a relative. In order to provide not only cardiovascular risk 
assessment, but also provision of upstream lifestyle risk management services and 
behavioural change. This demonstrates the philosophy of the NHS Next Stage 
Review that prevention is everybody’s business and requires collaborative working 
and partnerships across care pathways between primary and secondary care to 
provide for identification and management of individuals at high cardiovascular risk 
and thereby contribute to the reduction in premature CVD burden and health 
inequalities overall.  
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